FDA warns about sterile drug products from Medaus Pharmacy

A lack of sterility assurance has prompted FDA to warn patients and health care providers not to use unexpired drug products that are intended to be sterile from Medaus Pharmacy. A recent inspection of the Birmingham, AL company’s facility revealed insanitary conditions, including poor sterile production practices.
A lack of sterility assurance has prompted FDA to warn patients and health care providers not to use unexpired drug products that are intended to be sterile from Medaus Pharmacy. A recent inspection of the Birmingham, AL company’s facility revealed insanitary conditions, including poor sterile production practices. Medaus was ordered by the Alabama Board of Pharmacy to halt sterile compounding operations on March 22. One week later, FDA recommended that the company recall all unexpired drug products that are intended to be sterile. Thus far, Medaus has not yet voluntarily recalled any drug products intended to be sterile, prompting FDA’s warning about the products. So far, FDA has not received any reports of adverse events associated with Medaus products.
See More At: http://www.pharmacist.com/fda-warns-about-sterile-drug-products-medaus-pharmacy

Leave a Reply

avatar
  Subscribe  
Notify of